Free Trial

IM Cannabis Q2 2023 Earnings Report

IM Cannabis logo
$2.08 +0.08 (+4.00%)
(As of 12/20/2024 05:31 PM ET)

IM Cannabis EPS Results

Actual EPS
-$1.14
Consensus EPS
-$0.78
Beat/Miss
Missed by -$0.36
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$9.83 million
Expected Revenue
$10.17 million
Beat/Miss
Missed by -$340.00 thousand
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

IM Cannabis Earnings Headlines

IM Cannabis Corp Raises Funds Amid Global Challenges
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
DeFi Coin on Verge of Breakout!
The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.
IM Cannabis Reports Third Quarter Financial Results
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings